Brief: Hemostemix says Criterium notified it has terminated master services agreement

Hemostemix

28/06/2016 21:01

June 28 (Reuters) - Hemostemix Inc  HEM.V : 
    * Criterium notified co it has terminated master services 
agreement dated June 7, 2014 relating to clinical research 
services 
    * Hemostemix is placing a temporary hold on enrollment for 
its phase 2 clinical trials in canada and south africa 
    * Criterium will no longer be providing any services for 
hemostemix phase 2 clinical trials 
    * Currently evaluating its options as to how it will 
continue with clinical trials and to ensure patient follow up 
    * Hemostemix has made decision to temporarily cease 
enrolling any new patients into trial 
    * With respect to previously announced private placement 
financing, Hemostemix announces financing is proceeding 
    * Structure of offering may be amended to include a 
combination of equity and debt 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nCCNF1V7r 
Further company coverage:  HEM.V  
 
 (Bengaluru Newsroom: +1-646-223-8780)